APVO

Aptevo Therapeutics Inc

0.33

-0.02-7.02%

After Hours: 0.3121 -0.02 -5.42%16:48 09/16 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.3700/0.3549

TODAY RANGE0.3000-0.3833

VOL25.29M

MARKET CAP3.11M

52 WEEK RANGE0.2848-21.64

AVG VOL (3M)6.33M

% TURNOVER268.39%

TURNOVER--

P/E (TTM)-0.0072

% RANGE23.47%

EPS(TTM)-45.6255

P/E(FORWARD)-0.0164

P/B0.3017

BVPS1.094

DIVIDEND--

P/S3.509

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.11M

SHARES OUTSTANDING9.42M

NEXT EARNINGS11/12-11/18

FREE FLOAT9.42M

LOT SIZE1

EX-DIV DATE03/06/2024

News

Press Releases

Financial Reports

Profile

Latest

Popular

Reuters·8h ago
ALLIGATOR BIOSCIENCE AB - CO AND APTEVO THERAPEUTICS TODAY ANNOUNCED POSITIVE INTERIM DATA FROM DOSE ESCALATION PHASE OF THEIR PHASE 1 TRIAL EVALUATING ALG.APV-527 FOR TREATMENT OF SOLID TUMORS LIKELY TO EXPRESS TUMOR ANTIGEN 5T4
Dow Jones·08/30 21:42
*Aptevo Therapeutics Selling Up to 13.5M Shares Together With Up to 27M Warrants
NASDAQ·08/15 16:00
Aptevo Therapeutics (APVO) Upgraded to Buy: Here's What You Should Know
Reuters·08/13 12:13
APTEVO THERAPEUTICS: APVO436 RENAMED AS MIPLETAMIG
Investorplace·08/08 17:53
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024
Reuters·08/08 14:47
Aptevo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Reuters·08/08 12:21
APTEVO THERAPEUTICS: QTRLY SHR LOSS $1.67
Investorplace·07/18 11:31
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Seeking Alpha·06/28 14:50
Aptevo Therapeutics announces $2.75M offering priced at-the-market
Reuters·06/28 13:22
APTEVO THERAPEUTICS ANNOUNCES $2.75 MLN OFFERING PRICED AT--MARKET UNDER NASDAQ RULES
Investorplace·06/17 11:40
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Dow Jones·06/14 21:19
*Aptevo Therapeutics to Offer Up to 6M Shrs and 12M Warrants
Seeking Alpha·06/14 20:43
Aptevo Therapeutics files to sell 6.02M shares of common stock
NASDAQ·05/28 12:19
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Investorplace·05/08 16:54
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024

Same Industry

Name/Symbol

Change%

Price

Aptevo Therapeutics Inc

APVO

-7.02%

0.3300

Regeneron Pharmaceuticals

REGN

-0.02%

Entero Therapeutics

ENTO

+4.90%

0.3661

BIONTECH

BNTX

+0.06%

123.47

United Therapeutics Corp.

UTHR

+1.73%

344.98

Vertex Pharmaceuticals Inc

VRTX

+0.84%

489.43

Siga Technologie

SIGA

+1.14%

7.99

Moderna

MRNA

+1.30%

69.17

Charles Riv Labs Intl Inc

CRL

+2.58%

203.73

Medpace Holdings

MEDP

+1.43%

356.69

Talphera Inc

TLPH

-2.22%

0.8800

ICON PLC

ICLR

-1.47%

295.58

China Biologic

CBPO

119.99

Iqvia Hldgs Inc

IQV

+0.28%

239.38

MOLECULAR PARTNERS AG

MOLN

-0.19%

5.21

Gilead Sciences Inc

GILD

+0.42%

83.16

PRA Health

PRAH

165.21

Arcturus Therape

ARCT

-0.67%

20.61

Incyte Corp

INCY

+4.48%

66.41

Biospecifics

BSTC

+0.15%

88.53

Kiniksa Pharmaceuticals International, plc

KNSA

-0.40%

25.16

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.